Pediatric Indication Expansion

About Beta Bionics

Beta Bionics is a commercial-stage private company that has developed the iLet Bionic Pancreas, a differentiated automated insulin delivery system. The iLet's key differentiator is its algorithm, which requires only a user's body weight to initialize and then autonomously learns and adapts insulin delivery, eliminating the need for manual carb counting and dose calculations. The system is integrated with leading CGM sensors from Dexcom and Abbott and represents a significant step towards a fully autonomous, decision-free management solution for type 1 diabetes.

Therapeutic Areas